Buy RTO by Jan 4, 2027.

Rentokil Initial looks like a possible overreaction play, pulling back from over 600p down to around 380p to 400p in London and $20 to $24 on its US listing, where it trades at roughly 13x to 15x forward earnings—well below its historical mid-20s multiple and a massive discount to main peer Rollins at over 30x—despite pulling in 6.9 billion USD in annual revenue with 615 million USD in free cash flow. The sell-off was mostly driven by integration hiccups and …